A GSL Switch is Unlikely in the Current Climate Despite a recent drive by the Department of Health and Social Care (DHSC) to encourage the reclassification of certain medicines (like those for pain, sleep aids, and skin conditions) to P or GSL status, a switch for injectable B12 is not on the cards
Confirmed risks from preclinical data Renal toxicity
FUBAR ARNOLD MEDIA Related Speakers 2026 United Talent Rights Reserved
If you take BPC-157 via an injection, you may get: Itchiness, pain, or numbness at the injection site Vein, muscle, or skin discomfort Higher blood pressure Increased water retention Unintentional weight gain/loss Tiredness Who Can Benefit From BPC-157
Direct eyesight improvement, meaning enhanced visual acuity in healthy eyes or reversal of refractive errors, lacks strong evidence